Bayer - About the company
Bayer is a public company based in Leverkusen (Germany), founded in 1863. It operates as a Manufacturer of drugs. Bayer has raised an undisclosed amount in funding. The company has 198 active competitors, including 13 funded and 53 that have exited. Its top competitors include companies like Wockhardt, Biological E and Cipla.
Company Details
Manufacturer of drugs. It targets women's health, cardiology, oncology, hematology, ophthalmology, and radiology.
- Website
- www.bayer.com/
- Email ID
- *****@bayer.com
- Phone Number
- +49 **********
- Registered Address
- St Louis, Missouri
Key Metrics
Founded Year
1863
Location
Leverkusen, Germany
Stage
Public
Latest Funding Round
Investors
Ranked
1st among 198 active competitors
Employee Count
95,959 as on Sep 30, 2026
Exit Details
Public
Legal entities associated with Bayer
Bayer is associated with 22 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
BAYER a BAYER s.r.o. CIN: 63217406 , Czech Republic, Active | Mar 09, 1995 | - | - | |
HELF, spol. s r.o. CIN: 62363417 , Czech Republic, Active | Mar 09, 1995 | - | - | |
BLOK, spol. s r.o. CIN: 46995722 , Czech Republic, Active | Dec 18, 1992 | - | - | |
SKSK s.r.o. CIN: 28846770 , Czech Republic, Active | Apr 05, 2012 | - | - | |
Baier 2 spol. s r.o. CIN: 21384789 , Czech Republic, Active | Apr 01, 2024 | - | - | |
Czech Pills Group s.r.o. CIN: 19664061 , Czech Republic, Active | Aug 30, 2023 | - | - | |
BAYER CZ s.r.o. CIN: 09916008 , Czech Republic, Active | Feb 12, 2021 | - | - | |
commerz-data.eu, spol. s r.o. CIN: 06487882 , Czech Republic, Active | Oct 03, 2017 | - | - | |
Bayer CIN: 40103182449 , Latvia, Active | Jul 24, 2008 | €1M - €10M (As on Dec 31, 2024) | 44 (As on Dec 31, 2022) | - |
BAYER AEH LIMITED CIN: 863087 , United Kingdom, Active | Nov 01, 1965 | - | - | |
BAYER FULL TRANSPORT LTD CIN: 12657085 , United Kingdom, Active | Jun 08, 2020 | - | 1 (As on Jun 30, 2021) | |
BAYER BIOSCIENCE PRIVATE LIMITED CIN: U74899MH1977PTC179722 , India, Active | Feb 28, 1977 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | - | |
MAHYCO MONSANTO BIOTECH (INDIA) PRIVATE LIMITED CIN: U73100MH1997PTC111505 , India, Active | Oct 23, 1997 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | - | |
BAYER INVESTMENTS INDIA PRIVATE LIMITED CIN: U65191MH2014PTC254886 , India, Active | Mar 24, 2014 | ₹50 - ₹100 Cr (As on Mar 31, 2025) | - | |
BAYER ZYDUS PHARMA PRIVATE LIMITED CIN: U24233MH2011PTC213118 , India, Amalgamated | Feb 07, 2011 | ₹500 - ₹1,000 Cr (As on Mar 31, 2025) | 688 (As on Oct 31, 2024) | |
BAYER SCIENCE AND INNOVATION PRIVATE LIMITED CIN: U24110MH1996PTC096340 , India, Active | Jan 16, 1996 | ₹500 - ₹1,000 Cr (As on Mar 31, 2025) | 1160 (As on Mar 31, 2024) | |
BAYER FOUNDATION INDIA CIN: U85191MH2011NPL220674 , India, Active | Aug 08, 2011 | 0 - ₹10 Cr (As on Mar 31, 2025) | - | |
BAYER PHARMACEUTICALS PRIVATE LIMITED CIN: U05195MH1998PTC116021 , India, Active | Jul 29, 1998 | ₹1,000+ Cr (As on Mar 31, 2026) | 1333 (As on Feb 01, 2026) | |
BAYER CROPSCIENCE LIMITED CIN: L24210MH1958PLC011173 , India, Active | Sep 09, 1958 | ₹1,000+ Cr (As on Mar 31, 2025) | 1083 (As on Feb 29, 2024) | |
BAYER VAPI PRIVATE LIMITED CIN: U99999GJ1990PTC049322 , India, Active | Aug 08, 1990 | ₹1,000+ Cr (As on Mar 31, 2025) | 1166 (As on Feb 01, 2026) | |
Bayer Aktiengesellschaft CIN: HRB48248 , Germany, Active | Jan 14, 1952 | €1B+ (As on Dec 31, 2023) | 99538 (As on Dec 31, 2020) | |
BAYER CORPORATION CIN: 251339219 , United States, Active | Dec 26, 999 | - | 313 (As on Dec 31, 2024) | - |
Bayer's IPO details
Bayer got listed on Jan 10, 1953.
Click here to take a look at Bayer's IPO in detail
Sign up to download Bayer's company profile
Bayer's funding and investors
Bayer has raised funding over 26 rounds. Its first funding round was on Jul 15, 2010. Its latest funding round was a Grant (prize money) round on Oct 21, 2022 for $*****. 1 investor participated in its latest round. Bayer has 11 institutional investors.
Here is the list of recent funding rounds of Bayer:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 21, 2022 | 2855249 | Grant (prize money) | 4857988 | 6836029 | 8625227 | 2594372 |
Jun 01, 2021 | 8245715 | Grant (prize money) | 2072492 | 9285739 | 2868919 | |
May 31, 2021 | 9421592 | Grant (prize money) | 1560366 | 2947018 | 5937195 |
View details of Bayer's funding rounds and investors
Bayer's founders and board of directors
Founder? Claim ProfileBayer's Board of Directors
Bayer's board has 7 active members. Sanjiv Rangrass, Radhika Govind Rajan, Ravi Moti Kirpalani, Thomas Hoffmann, Simon Thorsten Wiebusch, Jana Marlen Ackermann and Vinit Rajesh Jindal are independent board members.Here is the list of Bayer's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 1y 2m | |
xaxd{ev | Independent board member | - | Current | 7y 5m |
r{xnaju | Independent board member | - | Current | 9y 5m |
labydjz | Independent board member | - | Current | 8y 3m |
xg{qtpq | Independent board member | - | Current | 2y 3m |
ahqgycx | Independent board member | - | Current | 4y 2m |
dssdqli | Independent board member | - | Current | 2y 1m |
Bayer's employee count trend
Bayer has 95,959 employees as of Sep 26. Here is Bayer's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bayer's Competitors and alternates
Top competitors of Bayer include Wockhardt, Biological E and Cipla. Here is the list of Top 10 competitors of Bayer, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of drugs | - | 76/100 | ||
2nd | Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients | - | 71/100 | ||
3rd | Biological E 1953, Hyderabad (India), Funding Raised | Developer of vaccines for treating multiple diseases | - | 69/100 | |
4th | Manufacturer of APIs, generic drugs, and formulation development services | - | 69/100 | ||
5th | Developer, manufacturer, and markets a broad range of pharmaceutical products | $50M | 68/100 | ||
6th | Amneal 2002, Bridgewater (United States), Public | Manufacturer of generics formulations | - | 68/100 | |
7th | Strides Pharma Science 1990, Bengaluru (India), Public | Manufacturer of generic pharmaceutical products and various specialty medical formulations | - | 68/100 | |
8th | Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients | - | 67/100 | ||
9th | Aurobindo Pharma 1986, Hyderabad (India), Public | Provider of generic biocatalytic products | - | 66/100 | |
10th | Dr. Reddy's Laboratories 1984, Hyderabad (India), Public | Multinational pharmaceutical company that develops and manufactures innovative and medicines to improve patient health | - | 65/100 |
Looking for more details on Bayer's competitors? Click here to see the top ones
Bayer's Investments and acquisitions
Bayer has made 56 investments in companies including Leaf and Ukko. Bayer has also acquired 40 companies including Perfuse Therapeutics and Cara Care.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jun 11, 2026 | Investments | 2018 | Los Angeles (United States) | |
May 06, 2026 | Acquisition | 2018 | San Francisco (United States) | |
Jan 08, 2026 | Investments | 2017 | Palo Alto (United States) |
See all investments and acquisitions by Bayer
Reports related to Bayer
Here is the latest report on Bayer's geography:
News related to Bayer
Media has covered Bayer for a total of 215 events in the last 1 year, 77 of them have been about company updates and 22 about partnerships.
•
•
Viralgen Announces Planned CEO Succession, Strengthening Gene Therapy ManufacturingEuropa Press•Oct 19, 2026•Viral Gen, Bayer
•
Sopris Capital Acquires Blackford Analysis to Enhance AI Orchestration in HealthTechPR Newswire•Oct 09, 2026•Sopris Capital, Bayer, Blackford Analysis
•
•
Bayer invests $2.2 billion in new US pharmaceutical plant in OhioFinanzNachrichten•Oct 03, 2026•Bayer
•
Bayer Faces Trial Test of Remaining Roundup Claims After Supreme Court WinInsurance Journal•Oct 01, 2026•Bayer
•
Brazil and US Companies Collaborate on Agricultural Sustainability and Carbon Credit ProjectsGrupoglobo•Sep 30, 2026•Minerva Foods, Bayer, Brandt, Coill and 1 other
•
U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® elinzanetant for a New IndicationBusiness Wire•Sep 28, 2026•Bayer
•
Bayer Launches RecyClass-Certified Mono-Material Polypropylene Blister for Talcid in GermanyEuropaWire•Sep 24, 2026•Bayer
•
Vividion Investor Wants IP Suit Over $2B Bayer Deal RevivedLaw360•Sep 24, 2026•Vividion Therapeutics, Bayer
Are you a Founder ?
FAQs about Bayer
Explore our recently published companies
- BrightGene - Suzhou based, 2001 founded, Series C company
- Linzess - Boston based, Unfunded company
- CTCBIO - Seoul based, 1993 founded, Public company
- Apollo Generics - United Kingdom based, 2006 founded, Unfunded company
- Hubei Tangren Pharmaceutica - Wuhan based, 2003 founded, Unfunded company
- Rontis - Zug based, 1986 founded, Unfunded company